Novo Nordisks collaboration with United Laboratories International focuses on UBT251, a triple agonist targeting GLP-1, GIP, and glucagon receptors
According to Grant Martsolf, a nursing services researcher at the University of Pittsburgh, the NP category was originally created because there were a lot of long-serving nurses who were more experienced and frankly more knowledgeable than younger MDs and DOs
NICE and MHRA updates highlight that these effects usually ease with time and are lessened by slow dose titration
Increased heart rate is a recognised pharmacological effect of GLP-1 receptor agonists
Tirzepatide is a highly effective medication for weight loss that works by controlling appetite and regulating blood sugar
However, if you have any reason to combine both medications, ensure you consult the right healthcare professional first